IFGL Stock News 31.52 05/13/2014 11:09:21 FTSE Epra/Nareit Dev

New Post Public Reply Private Reply Replies (0) Message Board

May 13, 2014 at 12:09 PM

FTSE Epra/Nareit Dev Re Ex-US Ishares (IFGL) 31.52 $IFGL

iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund Shares Down 10.9% Since SmarTrend's Sell Call (IFGL)
Comtex SmarTrend(R) - Tue Feb 04, 11:20AM CST
SmarTrend identified a Downtrend for iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund (NASDAQ:IFGL) on December 4th, 2013 at $32.66. In approximately 2 months, iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund has returned 10.89% as of today's recent price of $29.10.

RBS, DCE, IFGL, DOD, IGF, URZ Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Wed Jul 10, 6:10AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Royal Bank of Scotland Group PLC (NYSE:RBS), Deutsche Bank Capital Funding Trust X (NYSE

CE), iShares FTSE EPRA/NAREIT Global Real Estate ex-U.S. Index Fund (NASDAQ:IFGL), Diamond Frank Exploration Inc (NYSE

OD), Ishares S&P Global Infrastructure Index Fund (NYSE:IGF), Uranerz Energy Corp (AMEX:URZ) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

Real Estate Is a Bargain
Blogs @ The Motley Fool - Motley Fool - Thu Jun 27, 2:50PM CDT
A Real Estate Investment Trust (REIT) is "any corporation, trust or association that acts as an investment agent specializing in real estate and real estate mortgages" according to U.S. Federal income tax law. In layman's terms, this...

20.7% Return Seen to Date on SmarTrend iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund Call (IFGL)
Comtex SmarTrend(R) - Thu May 23, 10:56AM CDT
SmarTrend identified an Uptrend for iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund (NASDAQ:IFGL) on June 19th, 2012 at $28.23. In approximately 11 months, iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund has returned 20.65% as of today's recent price of $34.06.

Shares of IFGL Up 29.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu May 02, 9:40AM CDT
SmarTrend identified an Uptrend for iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund (NASDAQ:IFGL) on June 19th, 2012 at $28.23. In approximately 11 months, iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund has returned 29.65% as of today's recent price of $36.60.

SKH, IFGL, AIA, IFSM, CLFD Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Mon Apr 29, 5:48AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Skilled Healthcare Group Inc (NYSE:SKH), iShares FTSE EPRA/NAREIT Global Real Estate ex-U.S. Index Fund (NASDAQ:IFGL), ISHARES S&P ASIA 50 INDEX FUND (NYSE:AIA), Ishares Msci Eafe Value * (NASDAQ:IFSM), Clearfield Inc (NASDAQ:CLFD) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund Has Returned 28.2% Since SmarTrend Recommendation (IFGL)
Comtex SmarTrend(R) - Thu Apr 25, 9:09AM CDT
SmarTrend identified an Uptrend for iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund (NASDAQ:IFGL) on June 19th, 2012 at $28.23. In approximately 10 months, iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund has returned 28.23% as of today's recent price of $36.20.

Uptrend Call Working As iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund Stock Rises 26.0% (IFGL)
Comtex SmarTrend(R) - Wed Apr 17, 4:41PM CDT
SmarTrend identified an Uptrend for iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund (NASDAQ:IFGL) on June 19th, 2012 at $28.23. In approximately 10 months, iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund has returned 25.97% as of today's recent price of $35.56.

iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund Up 26.3% Since SmarTrend Uptrend Call (IFGL)
Comtex SmarTrend(R) - Wed Apr 10, 11:00AM CDT
SmarTrend identified an Uptrend for iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund (NASDAQ:IFGL) on June 19th, 2012 at $28.23. In approximately 10 months, iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund has returned 26.26% as of today's recent price of $35.64.

WEALTHMAKERS.COM Issues Bullish Research Reports on CLNY, FMER, GSBC, HIBB, IFF, IFGL
M2 - Tue Mar 19, 10:37AM CDT
WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued new research reports today on the following stocks: Colony Financial Inc (NYSE:CLNY), Firstmerit Corp (NASDAQ:FMER), Great Southern Bancorp Inc (NASDAQ:GSBC), Hibbett Sports Inc (NASDAQ:HIBB), International Flavors & Fragrances Inc (NYSE:IFF), iShares FTSE EPRA/NAREIT Global Real Estate ex-U.S. Index Fund (NASDAQ:IFGL)

WEALTHMAKERS.COM Issues Bullish Research Reports on FMCN, FNLC, HI, HOME, IFGL, MELI
M2 - Mon Mar 18, 11:18AM CDT
WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued new research reports today on the following stocks: Focus Media Holding Ltd (NASDAQ:FMCN), First Bancorp Inc (NASDAQ:FNLC), Highland Resources Inc (NYSE:HI), Home Federal Bancorp Inc (NASDAQ:HOME), iShares FTSE EPRA/NAREIT Global Real Estate ex-U.S. Index Fund (NASDAQ:IFGL), MercadoLibre Inc (NASDAQ:MELI)

iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund Shares Up 20.0% Since SmarTrend's Buy Recommendation (IFGL)
Comtex SmarTrend(R) - Mon Mar 11, 9:56AM CDT
SmarTrend identified an Uptrend for iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund (NASDAQ:IFGL) on June 19th, 2012 at $28.23. In approximately 9 months, iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund has returned 20.01% as of today's recent price of $33.88.

19.2% Return Seen to Date on SmarTrend iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund Call (IFGL)
Comtex SmarTrend(R) - Mon Mar 04, 9:39AM CST
SmarTrend identified an Uptrend for iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund (NASDAQ:IFGL) on June 19th, 2012 at $28.23. In approximately 9 months, iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund has returned 19.23% as of today's recent price of $33.66.

iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund Shares Up 17.5% Since SmarTrend's Buy Recommendation (IFGL)
Comtex SmarTrend(R) - Wed Jan 23, 11:06AM CST
SmarTrend identified an Uptrend for iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund (NASDAQ:IFGL) on June 19th, 2012 at $28.23. In approximately 7 months, iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund has returned 17.53% as of today's recent price of $33.18.

iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund Up 17.9% Since SmarTrend Uptrend Call (IFGL)
Comtex SmarTrend(R) - Fri Jan 11, 4:57PM CST
SmarTrend identified an Uptrend for iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund (NASDAQ:IFGL) on June 19th, 2012 at $28.23. In approximately 7 months, iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund has returned 17.89% as of today's recent price of $33.28.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

FDA Greenlights Halozyme's Cancer Treatment Breakthrough

FDA's Seal of Approval: A Game Changer Well, folks, here's a twist in the story of cancer treatment with FDA giving a nod to RYBREVANT FASPRO. Johnson & Johnson's latest offering, fueled by Halozyme's groundbreaking ENHANZE technology, just snagged accelerated approval. We're not just talking any old treatment here; it's a dual-targeted therapy for head and neck cancer...

Investor Bidding on Off-Market Homes Surges 35% Higher

Investor Frenzy in Off-Market Real Estate Looking at the real estate puzzle today, one might spot an unexpected surge in enthusiasm for off-market residential properties. We've got iFinder Offers, a real estate platform that's made it its business to connect the dots between homeowners and a gaggle of over 325 hungry investors. And according to their magic spreadsheets,...

CalExitNow Push for CA GOP Ban & Sovereignty Talks

California's Political Pot Stirs In the wild world of politics, California stands as a fiery beacon yet again. This time, CalExitNow, a fiery group championing California's self-determination, is taking aim at the state’s Republican Party. Reminds me of a stock under pressure—hesitate at your peril as the winds of change sweep through. Disqualification Petition: A...

INOVIO's $75M Offering: A Tough Medicine for Investors

A Shot in the Arm or a Sore Spot? INOVIO Pharmaceuticals is diving headfirst into the capital markets with a $75 million public offering, and let me tell you, the road ahead isn't paved with gold, yet. They've set out to raise funds by pricing 58,747,235 shares at $1.05 a pop, which might have you scratching your head if you're holding INO shares already. Breaking Down...

AiNET Prevails in Breach of Contract Jury Verdict

AiNET's Legal Triumph Shakes Up the IT Sector Well, talk about a courtroom drama. Greenberg Traurig just snagged a big win for AiNET over in Prince George's County, Maryland, and it's a classic reminder that due diligence isn't just a nice-to-have—it's a must. AiNET found itself in the center of a breach of contract brawl with Tech Finance Co., and guess what? The jury...

Lilly's Digital Healthcare Push with Hims & Hers

Revolutionizing Access: Pharmaceuticals Meet Telehealth In an era where digital disruption is shaking every sector, Eli Lilly (NYSE:LLY) isn't sitting idle. They've just forged a partnership with Hims & Hers (NYSE:HIMS), one that's diving headfirst into the telehealth revolution. We're talking a slick merger of pharmaceuticals and digital platforms—offering FDA-approved...

Everest Group Faces Class Action: Key Investor Moves

Everest Group's Legal Spiral: What's Happening? Folks, when a company feels like it's caught in an endless storm, investors better hold on tight. That's the situation Everest Group, Ltd. finds itself in, with an 11.4% stock dive that’s got investors reeling. Securities fraud allegations are rocking Everest like a hurricane, and The Law Offices of Frank R. Cruz have put...

Brian Long Exits Atlantic Bridge for US Tech Fund

Well, here we go again with another shake-up in the tech investment world. Brian Long, a name that's been whispered around more than a few boardroom tables, is dropping out of Atlantic Bridge to start his own gig across the pond in the United States. If you're tracking numbers, Atlantic Bridge is juggling a healthy €1.4bn in assets—no small potatoes. So, let's dig...

LaserAway Opens 241st Clinic, Marks 20-Year Milestone

LaserAway's New Chapter in Paramus Out of the glitz of Los Angeles and into the hustle of Paramus, LaserAway's latest clinic isn't just a ribbon-cutting ceremony—it's a milestone in the aesthetic dermatology space. Boasting its 241st location, LaserAway is marking twenty years of relentless expansion without ever closing a single clinic. Now that's a track record that'd...

TELUS Targets Debt Reduction Amid Telecom Transformation

Adjusting Strategy Amid Financial Challenges The market's a tough beast, and TELUS seems to be wrestling with it, showing both grit and foresight in its latest quarterly update. Third quarter 2026 has TELUS down on revenues with a notable net loss but don't count them out yet. Their Transformation Strategy is a gamble worth watching. Where the Numbers Stand Here's the...